Aethlon Medical Q1 FY27 net loss narrows 12.12% to $1.55 million

Reuters2026/08/13 20:26

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Aethlon Medical posted a net loss attributable to common stockholders of $1.55 million, improving from $1.76 million a year earlier.
Operating loss narrowed 11.9% to $1.58 million, on lower professional fees and reduced general and administrative costs.
Cash and cash equivalents totaled $4.93 million at June 30, down from $5.03 million at March 31.
Subsequent to quarter-end, it raised $4 million in gross proceeds via a public offering, funding operations for at least 12 months.
Program update: first participant dosed in the third and final cohort of its Phase 1 oncology study in Australia; Long COVID manuscript accepted.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608131615PR_NEWS_USPR_____LA25318) on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Aethlon Medical Q1 FY27 net loss narrows 12.12% to $1.55 million

You may also like

Crypto prices